Is ALX Oncology Holdings financially healthy?
Not really
ALX Oncology Holdings earns only -105.4 times its interest bill, which leaves little room.
The numbers behind it
Net debt / EBITDA0.3 years
Cash vs. debt$16M vs. $10M
Current ratio7.2×Short-term assets for each $1 of bills due within a year
Interest coverage-105.4×How many times operating profit covers the interest bill
How we decide
We measure debt in years of earnings (net debt / EBITDA): under 1 is very comfortable, 1 to 3 is manageable, above 3 is heavy. A company that earns less than 3 times its interest bill also counts as weak.
More questions about ALX Oncology Holdings
Data as of Nov 13, 2026.